Research Article
Phylogenetic Aspects of Antibiotic Resistance and Biofilm Formation of P. aeruginosa Isolated from Clinical Samples
Table 2
Antibiotic susceptibility patterns of P. aeruginosa isolates recovered from clinical specimens.
| | Specimen | CPR(%) | IPMR(%) | GMR(%) | ANR(%) | CAZR(%) | CROR(%) | FEPR(%) | MDR (N/%) | Specimen number (%) |
| | Urine | 6 | 6 | 3 | 3 | 3 | 7 | 3 | 5 (8.48) | 21 (35.6) | | Skin | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 0 (0) | 4 (6.8) | | Sputum | 6 | 6 | 0 | 0 | 0 | 6 | 0 | 2 (3.38) | 15 (25.42) | | Body fluid | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 (0) | 3 (5.08) | | Blood | 3 | 4 | 1 | 1 | 2 | 2 | 1 | 2 (3.38) | 6 (10.16) | | Wound | 8 | 9 | 6 | 5 | 6 | 9 | 6 | 7 (11.86) | 10 (16.94) | | Total | 25 (42.37) | 27 (45.76) | 10 (16.94) | 9 (15.25) | 11 (18.64) | 27 (45.76) | 10 (16.94) | 16 (27.11) | 59 (100) |
|
|
CP: ciprofloxacin, IPM: imipenem, GM: gentamicin, AN: amikacin, CAZ: ceftazidime, CRO: ceftriaxone, FEP: cefepime, and S/R: sensitive/resistance.
|
